Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
An Open-Label Study to Investigate the Pharmacokinetics of Bendamustine Hydrochloride in
Patients With Relapsed or Refractory Malignancy (Hematologic or Nonhematologic)